7:45 am Morning Networking Coffee & Registration
8:35 am Chairperson’s Opening Remarks
Navigating the Future Outlook of Successful mRNA-Based Vaccines and Therapeutics
8:45 am mRNA-1273 (Spikevax) – The Past, Present, & Future?
Synopsis
- Adult vaccine development
- Pediatric vaccine development
- Variant vaccine development
9:15 am Pharma Leaders Fireside Discussion
Synopsis
With the next wave of mRNA on the rise and with large pharma that were involved in prepandemic now having a validated platform on their hands to develop new therapeutics and vaccines, this leads to the inevitable question: What comes next? It is now important to realize the opportunities of such mRNA- based therapeutic applications, the
opportunities to develop global partnerships and collaboration as we hear from leading experts on the future of this technology
10:00 am Session Details To Be Confirmed
10:30 am Morning Structured Networking
1:00 pm Networking Lunch & Tech Slam
4:00 pm Afternoon Networking Break
4:30 pm Reserved for Applied DNA Sciences
Synopsis
- Session Details To Be Confirmed
5:00 pm Diversity, Equality & Inclusion Round Table: Prioritizing Diversity, Equality & Inclusion in the mRNA Industry
Synopsis
- What impacts are there on talent strategy in organizations today?
- What is something actionable people can do today to make the scientific field more inclusive?
- What developments and practices have organizations made or put in place that other leaders should consider adopting?
5:30 pm An Overview of the mRNA Landscape & Future Directions
Synopsis
- A brief overview of the RNA drug and trial landscape
- An in-depth analysis of the mRNA space and its development
- A look into the future of mRNA and emerging trends